REGN-15505

N/A

Report date: 2026/05/25 20:02:40

Base Information

Drug NameREGN-15505

Drug Alias NameREGN15505REGN-15505

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionAnti-PSMAAnti-Tumor necrosis factor receptor superfamily member 9

TargetsProstate-Specific Membrane AntigenTumor necrosis factor receptor superfamily member 9

Therapy Area/IndicationsProstatic Neoplasms, Castration-ResistantCarcinoma, Renal Cell

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesRegeneron Pharmaceuticals Inc

China Registration ClassN/A

Develop Information

Active CompaniesRegeneron Pharmaceuticals Inc

Inactive CompaniesN/A

Active IndicationsProstatic Neoplasms, Castration-ResistantCarcinoma, Renal Cell

Inactive IndicationsN/A

Other Information

ATC CodeN/A